The DOI matches its Crossref record, with a small difference in title or year; 94 of the 96 references it cites were found in a registry or an index; none of the 71 sources its claims cite is checked for support yet.
Obesity and Cardiovascular Disease
Open accessAbstract
Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases. Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival. Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/nonobese patients. This review summarizes the adverse effects of obesity on CV disease risk factors and its role in the pathogenesis of various CV diseases, reviews the obesity paradox and potential explanations for these puzzling data, and concludes with a discussion regarding the current state of weight reduction in the prevention and treatment of CV diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 of 71 cited sources checked · 0 supported · 0 flagged
In the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a small subgroup of 45 obese patients with 5% or more weight loss (average 10%) after cardiac rehabilitation, we noted more significant improvements in exercise capacity and plasma lipids than in 81 obese patients who did not lose weight (76).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [76] Lavie, 1997, Effects of cardiac rehabilitation, exercise training, and weight reduction on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in obese coronary patients, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 530 patients, we noted marked improvements in CHD risk factors among overweight and obese CHD patients who lost weight, including CRP, lipids, and glucose, and this group had a trend of lower mortality (48).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [48] Lavie, 2009, The obesity paradox, weight loss, and coronary disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“In a study of 5,881 Framingham Heart Study participants, Kenchaiah et al. (30) showed that during a 14-year follow-up, for every 1 kg/m 2 increment in BMI, the risk of HF increased 5% in men and 7% in women.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [30] Kenchaiah, 2002, Obesity and the risk of heart failure, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“These abnormalities not only increase the risk of HF, but LA enlargement may increase the risk of AF and its morbid complications discussed later (20).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [20] Wang, 2004, Obesity and the risk of new-onset atrial fibrillation, JAMA source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In contrast, however, other studies assessing mortality based on body fat and lean mass rather than BMI or weight alone have suggested that subjects losing body fat rather than lean mass have a lower mortality (67,69).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIn the paper
“During 2-year follow up, all-cause mortality was 30% lower in overweight and obese patients, despite less effective blood pressure control in these patients compared with the normal weight group.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [25] Uretsky, 2007, Obesity paradox in patients with hypertension and coronary artery disease, Am J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesNone of the sources cited for this claim have been checked yet.
In the paper
“In addition to LV structural abnormalities, obesity also leads to left atrial (LA) enlargement, both from increased circulating blood volume as well as abnormal LV diastolic filling (14,19).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIn the paper
“Even independent of arterial pressure and age, obesity increases the risk of left ventricular hypertrophy (LVH), as well as other structural abnormalities, including concentric remodeling (CR) and concentric LVH (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Despite this adverse association, numerous studies have documented an obesity paradox in which overweight and obese people with established CV disease, including HTN, HF, CHD, and peripheral arterial disease, have a better prognosis compared with nonoverweight/ nonobese patients.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passes
- It may state two separate claims as one. 26
- Probably not a substantial claim. 2
- The quote only partly states this claim. 2
In the paper
“Recently, we noted marked reductions after cardiac rehabilitation in CRP levels in obese CHD patients, whereas lean patients had only slight and nonsignificant declines in CRP (77).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [77] Lavie, 2008, Impact of cardiac rehabilitation on coronary risk factors, inflammation, and the metabolic syndrome in obese coronary patients, J Cardiometab Syndr source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Considering that some long-term studies have shown that weight loss in overweight and obesity is associated with increased mortality coupled with many CV studies showing a better prognosis with a higher BMI, it has been suggested that purposeful weight loss may not be beneficial and may even be detrimental in patients with CV diseases (31,66 -68).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [31] Horwich, 2001, The relationship between obesity and mortality in patients with heart failure, J Am Coll Cardiol source
- Not checked yetcites [66] Fonarow, 2002, Obesity, weight reduction and survival in heart failure: reply, J Am Coll Cardiol source
- Not checked yetcites [67] Allison, 1999, Weight loss increases and fat loss decreases all-cause mortality rates: results from two independent cohort studies, Int J Obes Relat Metab Disord source
- Not checked yetcites [68] Sierra-Johnson, 2008, Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index, Eur Cardiovasc Prev Rehabil source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesProbably not a substantial claim. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The adipocyte acts as an endocrine organ, and plays a substantial role in the pathogenesis and complications of obesity (1,10).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Recent evidence indicates that obesity is associated with more morbidity than smoking, alcoholism, and poverty, and if current trends continue, obesity may soon overtake cigarette abuse as the leading cause of preventable death in the U.S. (6 -8).”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
- Not checked yetcites [8] Sturm, 2001, Does obesity contribute as much to morbidity as poverty or smoking?, Public Health source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In fact, OSA may contribute to the pathogenesis of HTN and increased inflammation and CRP (61).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [61] Shamsuzzaman, 2002, Elevated C-reactive protein in patients with obstructive sleep apnea, Circulation source
Strength:hedged· not yet calibratedCausal:conditional· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“with the prevalence among adults increasing by nearly 50% during the 1980s and 1990s (5); now, nearly 70% of adults are classified as overweight or obese compared with fewer than 25% 40 years ago (5)(6)(7).”
What the sources say
- Not checked yetcites [5] Flegal, 2002, Prevalence and trends in obesity among US adults, 1999–2000, JAMA source
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
- Not checked yetcites [7] Manson, 2003, Obesity in the United States: a fresh look at its high toll, JAMA source
Strength:plain· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes✗ Load-bearing: fails✓ Based: passesProbably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Obesity is a classic cause of alveolar hypoventilation and the obstructive sleep apnea (OSA) syndrome (60).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > -Hippocrates (54)
What the sources say
- Not checked yetcites [60] Trollo, 1996, Obstructive sleep apnea, N Engl J Med source
Strength:plain· not yet calibratedCausal:direct· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“We have also documented the inverse relationship between BMI and all-cause mortality in over 30,000 patients with preserved LV systolic function referred for echocardiography (18).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [18] Lavie, 2007, Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one. The quote only partly states this claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Because of its maladaptive effects on various CV risk factors and its adverse effects on CV structure and function, obesity has a major impact on CV diseases, such as heart failure (HF), coronary heart disease (CHD), sudden cardiac death, and atrial fibrillation, and is associated with reduced overall survival.”
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“However, in patients with a BMI Ն35 kg/m 2 , there was an excess risk for CV mortality without any increase in total mortality.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [47] Romero-Corral, 2006, Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies, Lancet source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity has reached global epidemic proportions in both adults and children and is associated with numerous comorbidities, including hypertension (HTN), type II diabetes mellitus, dyslipidemia, obstructive sleep apnea and sleep-disordered breathing, certain cancers, and major cardiovascular (CV) diseases.”
What the sources say
- Not checked yetcites [6] Lavie, 2003, Obesity and cardiovascular disease: the Hippocrates paradox?, J Am Coll Cardiol source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Typically, obese patients have a higher cardiac output but a lower level of total peripheral resistance at any given level of arterial pressure (14,15).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“In the subgroup of 5 population-based studies enrolling 78,602 patients, obese patients had a nearly 50% increased risk of developing AF that escalated with increasing BMI.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [52] Wanahita, 2008, Atrial fibrillation and obesity—results of a meta-analysis, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Likewise, in an analysis of BMI and in-hospital mortality for 108,927 decompensated HF patients, higher BMI was associated with lower mortality (35).”
- Also stated in: § Clinical Consequences of Obesity · plain
“In fact, for every 5-unit increase in BMI, the risk of mortality was 10% lower (p Ͻ 0.001).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [35] Fonarow, 2007, An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the acute decompensated heart failure national registry, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
- Also stated in: § Clinical Consequences of Obesity · plain
In the paper
“A recent study of nearly 360,000 participants from 9 European countries showed that both general obesity and abdominal adiposity are associated with risk of death and support the importance of WC or WHR in addition to BMI for assessing mortality risk (4).”
What the sources say
- Not checked yetcites [4] Pischon, 2008, General and abdominal adiposity and risk of death in Europe, N Engl J Med source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Certainly, starvation, very-low-calorie diets, liquid protein diets, and obesity surgeries have been associated with prolongation of the QTc interval and increased risk of malignant dysrhythmias (1), and various pharmacologic agents have either limited efficacy or considerable toxicity (70 -72).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [1] Poirier, 2006, Circulation source
- Not checked yetcites [70] Connolly, 1997, Valvular heart disease associated with fenfluramine-phentermine, N Engl J Med source
- Not checked yetcites [71] Albenhaim, 1996, Appetite-suppressant drugs and the risk of primary pulmonary hypertension, N Engl J Med source
- Not checked yetcites [72] Zannad, 2002, Effects of sibutramine on ventricular dimensions and heart valves in obese patients during weight reduction, Am Heart J source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Obesity increases total blood volume and cardiac output, and cardiac workload is greater in obesity.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Effects of Obesity on Hemodynamics and CV Structure and Function
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“This study also showed a powerful obesity paradox, with progressive reductions in mortality in normal BMI, overweight, and obese groups compared with underweight patients.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Clinical Consequences of Obesity
What the sources say
- Not checked yetcites [50] Galal, 2009, The obesity paradox in patients with peripheral arterial disease: the influence of chronic obstructive pulmonary disease, Chest source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesThe quote only partly states this claim.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, for each 1-U increase in BMI, there was an increase of 4% in the risk of ischemic stroke and 6% for hemorrhagic stroke (1,53).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Obesity and stroke.
What the sources say
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In a multivariate model, leptin was an independent predictor of CV events, whereas CRP was not.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Recently, increased concentrations of both CRP and leptin were associated with an increased risk of major CV events, but leptin seems to be a more robust predictor (13).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Pathophysiology
What the sources say
- Not checked yetcites [13] Romero-Corral, 2008, Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population, Nat Clin Pract Cardiovasc Med source
Strength:hedged· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“a recent small study suggests that bariatric surgery is safe and effective in patients with severe systolic HF (87).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [87] Ramani, 2008, Safety and efficacy of bariatric surgery in morbidly obese patients with severe systolic heart failure, Clin Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“In HF, despite the obesity paradox, trials have suggested that weight loss can induce improvements in LV mass as well as in systolic and diastolic ventricular function (14).”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [14] Alpert, 2001, Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome, Am J Med Sci source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
In the paper
“Although 30-day mortality after gastric bypass has recently been reported to be higher than expected, closely linked to surgeon inexperience (80)”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [80] Flum, 2004, Impact of gastric bypass operation on survival: a population-based analysis, J Am Coll Surg source
Strength:plain· not yet calibratedCausal:correlational· not yet calibratedTests✓ Asserted: passes✓ Checkable: passes? Load-bearing: unclear✓ Based: passesIt may state two separate claims as one.
In the paper
“Weight loss also was associated with marked improvements in LV chamber size, LV end-systolic wall stress, and systolic and diastolic LV function.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [23] Alpert, 1997, Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss, Am J Cardiol source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies support purposeful weight reduction in overweight and obese CHD patients, despite the obesity paradox.”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“more studies are now showing that these surgical procedures are associated with short-and long-term improvements in major morbidity and all-cause mortality, particularly related with cancers, DM, and CV diseases”
§ STATE-OF-THE-ART PAPER Obesity and Cardiovascular Disease Risk Factor, Paradox, and Impact of Weight Loss > Status of Weight Reduction
What the sources say
- Not checked yetcites [81] Adams, 2007, Long-term mortality after gastric bypass surgery, N Engl J Med source
- Not checked yetcites [82] Sjöström, 2007, Effects of bariatric surgery on mortality in Swedish obese subjects, N Engl J Med source
- Not checked yetcites [83] Christou, 2004, Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients, Ann Surg source
Tests✓ Asserted: passes✓ Checkable: passes✓ Load-bearing: passes✓ Based: passesIt may state two separate claims as one.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Further weight reduction cannot be considered protective against CVD.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“If, at the population level, obesity is associated with an increased risk of CVD incidence and mortality, among those with established coronary artery disease, the evidence is contradictory.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
In the citing paper
“Systematic reviews of patients with coronary artery disease or undergoing PCI have suggested an 'obesity paradox' whereby obesity appears protective against an adverse prognosis.366 -369”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [369]
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873 · cited 1×
“Clearly lifestyle interventions, including exercise training and at least mild weight reduction with caloric restriction, showed a nearly 60% reduction in the risk of developing DM, which was considerably better than that noted in patients treated with metformin (73, 74 ).”
BackgroundPrevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects
Sjöström, L., Narbro, K., Sjöström, C. D., Karason, K., Larsson, B., Wedel, H., Lystig, T., Sullivan, M., Bouchard, C., Carlsson, B., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066254 · Cited by 4,668
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Long-term mortality after gastric bypass surgery
Adams, T. D., Gress, R. E., Smith, S. C., Halverson, R. C., Simper, S. C., Rosamond, W. D., LaMonte, M. J., Stroup, A. M., & Hunt, S. C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066603 · Cited by 2,572
General and abdominal adiposity and risk of death in Europe
Pischon, T., Boeing, H., Hoffmann, K., Bergmann, M., Schulze, M. B., Overvad, K., van der Schouw, Y. T., Spencer, E., Moons, K. G. M., Tjønneland, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801891 · Cited by 2,155
Romero-Corral, A., Montori, V. M., Somers, V. K., Korinek, J., Thomas, R. J., Allison, T. G., Mookadam, F., & Lopez-Jimenez, F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69251-9 · Cited by 1,652
Valvular heart disease associated with fenfluramine-phentermine
Connolly, H. M., Crary, J. L., McGoon, M. D., Hensrud, D. D., Edwards, B. S., Edwards, W. D., & Schaff, H. V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370901 · Cited by 1,632
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J. (2004) · JAMA · doi:10.1001/jama.292.20.2471 · Cited by 1,427
Strollo, P. J., & Rogers, R. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340207 · Cited by 1,313
Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients
Christou, N. V., Sampalis, J. S., Liberman, M., Look, D., Auger, S., McLean, A. P. H., & MacLean, L. D. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000137343.63376.19 · Cited by 1,288
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L., Moride, Y., Brenot, F., Rich, S., Benichou, J., Kurz, X., Higenbottam, T., Oakley, C., Wouters, E., Aubier, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350901 · Cited by 1,162
Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea
Shamsuzzaman, A. S. M., Winnicki, M., Lanfranchi, P., Wolk, R., Kara, T., Accurso, V., & Somers, V. K. (2002) · Circulation · doi:10.1161/01.cir.0000018948.95175.03 · Cited by 974
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934
The relationship between obesity and mortality in patients with heart failure
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., Woo, M. A., & Tillisch, J. H. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01448-6 · Cited by 867
Zhang, C., Rexrode, K. M., van Dam, R. M., Li, T. Y., & Hu, F. B. (2008) · Circulation · doi:10.1161/circulationaha.107.739714 · Cited by 856
Body mass index and mortality in heart failure: a meta-analysis
Oreopoulos, A., Padwal, R., Kalantar-Zadeh, K., Fonarow, G. C., Norris, C. M., & McAlister, F. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.02.014 · Cited by 829
Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome
Alpert, M. A. (2001) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200104000-00003 · Cited by 795
Anker, S. D., Negassa, A., Coats, A. J. S., Afzal, R., Poole-Wilson, P. A., Cohn, J. N., & Yusuf, S. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12892-9 · Cited by 734
Cardiovascular Risk Factors and Venous Thromboembolism Incidence
Tsai, A. W., Cushman, M., Rosamond, W. D., Heckbert, S. R., Polak, J. F., & Folsom, A. R. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.10.1182 · Cited by 699
Kalantar‐Zadeh, K., Block, G., Horwich, T. B., & Fonarow, G. C. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.11.039 · Cited by 693
Long-term Outcome for Obstructive Sleep Apnea Syndrome Patients
Partinen, M., Jamieson, A. O., & Guilleminault, C. (1988) · CHEST Journal · doi:10.1378/chest.94.6.1200 · Cited by 659
A Prospective Study of Risk Factors for Pulmonary Embolism in Women
Goldhaber, S. Z. (1997) · JAMA · doi:10.1001/jama.1997.03540320044033 · Cited by 603
Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002
Ford, E. S., & Capewell, S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.05.056 · Cited by 589
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
Abenhaim, L. (1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)89579-7 · Cited by 562
Obesity paradox in patients with hypertension and coronary artery disease
Uretsky, S., Messerli, F. H., Bangalore, S., Champion, A., Cooper-DeHoff, R. M., Zhou, Q., & Pepine, C. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.05.011 · Cited by 550
The endotoxin-lipoprotein hypothesis
Rauchhaus, M., Coats, A. J. S., & Anker, S. D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02690-8 · Cited by 544
Obesity and suppressed B-type natriuretic peptide levels in heart failure
Mehra, M. R., Uber, P. A., Park, M. H., Scott, R. L., Ventura, H. O., Harris, B. C., & Frohlich, E. D. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.10.066 · Cited by 534
Self-citationImpact of gastric bypass operation on survival: a population-based analysis
Flum, D. R., & Dellinger, P. E. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.06.014 · Cited by 527
Body mass index and the risk of stroke in men
Kurth, T., Gaziano, J. M., Berger, K., Kase, C. S., Rexrode, K. M., Cook, N. R., Buring, J. E., & Manson, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2557 · Cited by 524
Martin, S. S., Qasim, A., & Reilly, M. P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.060 · Cited by 516
Fonarow, G. C., Srikanthan, P., Costanzo, M. R., Cintron, G. B., & Lopatin, M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2006.09.007 · Cited by 512
Body composition and prognosis in chronic systolic heart failure: the obesity paradox
Lavie, C. J., Osman, A. F., Milani, R. V., & Mehra, M. R. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00031-6 · Cited by 486
Self-citationAtrial fibrillation and obesity—results of a meta-analysis
Wanahita, N., Messerli, F. H., Bangalore, S., Gami, A. S., Somers, V. K., & Steinberg, J. S. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.10.004 · Cited by 474
Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
Mohamed‐Ali, V., Goodrick, S., Bulmer, K., Holly, J. M. P., Yudkin, J. S., & Coppack, S. W. (1999) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1999.277.6.e971 · Cited by 396
Differentiated long-term effects of intentional weight loss on diabetes and hypertension
Sjöström, C. D., Peltonen, M., Wedel, H., & Sjöström, L. (2000) · Hypertension · doi:10.1161/01.hyp.36.1.20 · Cited by 367
Measures of Obesity and Cardiovascular Risk Among Men and Women
Gelber, R. P., Gaziano, J. M., Orav, E. J., Manson, J. E., Buring, J. E., & Kurth, T. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.03.066 · Cited by 359
Cardiac failure and sudden death in the Framingham Study
Kannel, W. B., Plehn, J. F., & Cupples, L. A. (1988) · American Heart Journal · doi:10.1016/0002-8703(88)90891-5 · Cited by 326
Alpert, M. A., Terry, B. E., Mulekar, M., Cohen, M. V., Massey, C. V., Fan, T. M., Panayiotou, H., & Mukerji, V. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00505-5 · Cited by 325
THE MEDICAL WORKS OF HIPPOCRATES
Connell, W. K. (1951) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a074063 · Cited by 304
Enriori, P. J., Evans, A. E., Sinnayah, P., & Cowley, M. A. (2006) · Obesity · doi:10.1038/oby.2006.319 · Cited by 281
Overweight and sudden death. Increased ventricular ectopy in cardiopathy of obesity
Messerli, F. H. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.147.10.1725 · Cited by 260
Lavie, C. J., & Milani, R. V. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)89239-9 · Cited by 242
Self-citationThe obesity paradox, weight loss, and coronary disease
Lavie, C. J., Milani, R. V., Artham, S. M., Patel, D. A., & Ventura, H. O. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.06.006 · Cited by 237
Self-citationAllison, D., Zannolli, R., Faith, M., Heo, M., Pietrobelli, A., Vanltallie, T., Pi-Sunyer, F., & Heymsfield, S. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800875 · Cited by 236
Messerli, F. H. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370100039008 · Cited by 205
Risks and Benefits of Gastric Bypass in Morbidly Obese Patients With Severe Venous Stasis Disease
Sugerman, H. J., Sugerman, E. L., Wolfe, L. G., Kellum, J. M., Schweitzer, M. A., & DeMaria, E. J. (2001) · Annals of Surgery · doi:10.1097/00000658-200107000-00007 · Cited by 202
Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output
Messerli, F. H., Ventura, H. O., Reisin, E., Dreslinski, G. R., Dunn, F. G., MacPhee, A. A., & Frohlich, E. D. (1982) · Circulation · doi:10.1161/01.cir.66.1.55 · Cited by 201
Self-citationDoes obesity contribute as much to morbidity as poverty or smoking?
Sturm, R. (2001) · Public Health · doi:10.1016/s0033-3506(01)00449-8 · Cited by 194
Batsis, J. A., Romero‐Corral, A., Collazo–Clavell, M. L., Sarr, M. G., Somers, V. K., & López-Jiménez, F. A. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.8.897 · Cited by 178
Obesity and Age of First Non–ST-Segment Elevation Myocardial Infarction
Madala, M. C., Franklin, B. A., Chen, A. Y., Berman, A. D., Roe, M. T., Peterson, E. D., Ohman, E. M., Smith, S. C., Gibler, W. B., & McCullough, P. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.067 · Cited by 163
Obesity in the United States: A Fresh Look at Its High Toll
Manson, J. E., & Bassuk, S. S. (2003) · JAMA · doi:10.1001/jama.289.2.229 · Cited by 161
Lavie (2003) · doi:10.1016/s0735-1097(03)00784-8 · Cited by 160
Self-citationThe Obesity Paradox in Patients With Peripheral Arterial Disease
Galal, W., van Gestel, Y. R. B. M., Hoeks, S. E., Sin, D. D., Winkel, T. A., Bax, J. J., Verhagen, H., Awara, A. M. M., Klein, J., van Domburg, R. T., et al. (2008) · Chest · doi:10.1378/chest.08-0418 · Cited by 159
Milani, R. V., & Lavie, C. J. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00464-8 · Cited by 146
Self-citationRelation of Low Body Mass to Death and Stroke in the Systolic Hypertension in the Elderly Program
Wassertheil-Smoller, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.494 · Cited by 144
Lavie, C. J., Milani, R. V., Ventura, H. O., Cardenas, G. A., Mehra, M. R., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.040 · Cited by 131
Self-citationObesity and heart failure prognosis: paradox or reverse epidemiology?
Lavie, C. J., Mehra, M. R., & Milani, R. V. (2004) · European Heart Journal · doi:10.1093/eurheartj/ehi055 · Cited by 131
Self-citationEffects of obesity on QT, RR, and QTc intervals
El-Gamal, A. E. M., Gallagher, D., Nawras, A. T., Gandhi, P., Gómez, J. M., Allison, D. B., Steinberg, J. S., Shumacher, D., Blank, R. C., & Heymsfield, S. B. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80700-0 · Cited by 125
Ramani, G. V., McCloskey, C., Ramanathan, R. C., & Mathier, M. A. (2008) · Clinical Cardiology · doi:10.1002/clc.20315 · Cited by 123
Sierra-Johnson, J., Romero-Corral, A., Somers, V. K., Lopez-Jimenez, F., Thomas, R. J., Squires, R. W., & Allison, T. G. (2008) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e3282f48348 · Cited by 122
Cardiovascular Risk After Bariatric Surgery for Obesity
Batsis, J. A., Sarr, M. G., Collazo–Clavell, M. L., Thomas, R. J., Romero‐Corral, A., Somers, V. K., & López-Jiménez, F. A. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.05.040 · Cited by 109
Eilat-Adar, S. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi045 · Cited by 109
Stamler, R., Ford, C. E., & Stamler, J. F. (1991) · Hypertension · doi:10.1161/01.hyp.17.4.553 · Cited by 108
MacMahon, S., Collins, G., Rautaharju, P., Cutler, J., Neaton, J., Prineas, R., Crow, R., & Stamler, J. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90286-5 · Cited by 106
Abnormal left ventricular diastolic filling in eccentric left ventricular hypertrophy of obesity
Chakko, S. C., Mayor, M., Allison, M. D., Kessler, K. M., Materson, B. J., & Myerburg, R. J. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90718-z · Cited by 103
Litwin, S. E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.017 · Cited by 102
Myocardial contractility and left ventricular function in obese patients with essential hypertension
Garavaglia, G. E., Messerli, F. H., Nunez, B. D., Schmieder, R. E., & Grossman, E. (1988) · The American Journal of Cardiology · doi:10.1016/0002-9149(88)90662-5 · Cited by 102
Cardiopathy of Obesity — A Not-So-Victorian Disease
Messerli, F. H. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602063140608 · Cited by 99
Weight loss causes increased mortality: pros
Sørensen, T. I. A. (2003) · Obesity Reviews · doi:10.1046/j.1467-789x.2003.00090.x · Cited by 97
Left atrial abnormalities indicating diastolic ventricular dysfunction in cardiopathy of obesity
Lavie, C. J., Amodeo, C., Ventura, H. O., & Messerli, F. H. (1987) · Chest · doi:10.1378/chest.92.6.1042 · Cited by 91
Self-citationAPPETITE-SUPPRESSANT DRUGS AND THE RISK OF PRIMARY PULMONARY HYPERTENSION
Ucien, L., Benhaïm, A., Oride, Y. O. M., Renot, F. R. B., ICh, S., Acques, J., Enichou, B., Urz, X. A. K., Akley, C. E. O., Outers, E. M. W., et al. (2010) · Cited by 88
Body Mass, Fitness and Survival in Veteran Patients: Another Obesity Paradox?
McAuley, P. A., MYERS, J. N., Abella, J. P., & Froelicher, V. F. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.07.032 · Cited by 81
Cardiac Rehabilitation and Exercise Training Programs in Metabolic Syndrome and Diabetes
Lavie, C. J., & Milani, R. V. (2005) · Journal of Cardiopulmonary Rehabilitation · doi:10.1097/00008483-200503000-00001 · Cited by 78
Self-citationRomero-Corral, A., Sierra-Johnson, J., Lopez-Jimenez, F., Thomas, R. J., Singh, P., Hoffmann, M., Okcay, A., Korinek, J., Wolk, R., & Somers, V. K. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1218 · Cited by 77
Zannad, F., Gille, B., Grentzinger, A., Bruntz, J.-F., Hammadi, M., Boivin, J.-M., Hanotin, C., Igau, B., & Drouin, P. (2002) · American Heart Journal · doi:10.1067/mhj.2002.124403 · Cited by 71
Lavie, C. J., Morshedi‐Meibodi, A., & Milani, R. V. (2008) · Journal of the CardioMetabolic Syndrome · doi:10.1111/j.1559-4572.2008.00002.x · Cited by 61
Self-citationAbnormal Signal‐Averaged Electrocardiogram (SAECG) in Obesity
Lalani, A. P., Kanna, B., John, J., Ferrick, K. J., Huber, M. S., & Shapiro, L. E. (2000) · Obesity Research · doi:10.1038/oby.2000.4 · Cited by 59
Obesity, Heart Disease, and Favorable Prognosis—Truth or Paradox?
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.023 · Cited by 55
Self-citationValvular heart disease associated with fenfluramine-phentermine.
Kurz, X., & Ermen, A. V. (1997) · PubMed · Cited by 53
Obesity and the risk of new-onset atrial fibrillation
Wang, T. J., Parise, H., & Levy, D. A. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.02.017 · Cited by 48
QT Interval and QT Dispersion Before and After Diet Therapy in Patients with Simple Obesity
Mshui, M. E., Saikawa, T., Ito, K., Hara, M., & Sakata, T. (1999) · Experimental Biology and Medicine · doi:10.3181/00379727-220-44355 · Cited by 46
Tuomilehto, J. O. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90434-y · Cited by 42
The Relationship between QTc Changes and Nutrition during Weight Loss after Gastroplasty
Rasmussen, L. H., & Andersen, T. (1985) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1985.tb02694.x · Cited by 41
Catheter ablation for atrial fibrillation: Should it be first-line therapy?
Wharton, J. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.01.017 · Cited by 40
QT Interval and QT Dispersion Before and After Diet Therapy in Patients with Simple Obesity
Mshiu Merlyn, E., Saikawa, T., Ito, K., Hara, M., & Sakata, T. (1999) · Proceedings of The Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.1999.d01-20.x · Cited by 39
Lavie, C. J., Ventura, H. O., & Milani, R. V. (2008) · CHEST Journal · doi:10.1378/chest.08-1673 · Cited by 35
Self-citationObesity, weight reduction and survival in heart failure
Lavie, C. J., Milani, R. V., Mehra, M. R., Ventura, H. O., & Messerli, F. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01806-5 · Cited by 27
Self-citationUntangling the heavy cardiovascular burden of obesity
Lavie, C. J., Milani, R. V., & Ventura, H. O. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1257 · Cited by 24
Self-citationDoes body composition impact survival in patients with advanced heart failure
Lavie, C. J., Milani, R. V., Artham, S. M., Olivier, A. C., & Ventura, H. O. (2007) · Circulation · Cited by 10
Self-citationObesity, weight reduction and survival in heart failure: reply
Fonarow, G. C., Horwich, T. B., Hamilton, M. A., MacLellan, W. R., & Tillisch, J. H. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01807-7 · Cited by 7
Flagged first, then by citations
2 of the 96 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,419
Smith, S. C., Benjamin, E. J., Bonow, R. O., Braun, L. T., Creager, M. A., Franklin, B. A., Gibbons, R. J., Grundy, S. M., Hiratzka, L. F., Jones, D. W., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318235eb4d · Cited by 1,759
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,583
Metadata
- Authors
- Lavie, C. J., Milani, R. V., & Ventura, H. O.
- Affiliations
- Ochsner Health System (US)
- Ochsner Medical Center (US)
- Corresponding author
- Lavie, Carl J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 53
- Issue
- 21
- Pages
- 1925-1932
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1598667444
- Cited by
- 2,326
- References
- 96
- Citations by year
- 2026: 87 · 2025: 110 · 2024: 129 · 2023: 107 · 2022: 130 · 2021: 159 · 2020: 162 · 2019: 135 · 2018: 143 · 2017: 141 · 2016: 157 · 2015: 139 · 2014: 152 · 2013: 153 · 2012: 135
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Journal of the American College of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, obesity paradox, heart failure, coronary artery disease, sudden cardiac death, atrial fibrillation, hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular risk factors, weight loss, obesity pathogenesis
- MeSH terms
- Cardiovascular Diseases, Humans, Obesity, Risk Factors, United States, Weight Loss, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-04, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-04 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
